Scholar Rock Announces Design Of Phase 3 SAPPHIRE Clinical Trial Evaluating Apitegromab In Non-Ambulatory Patients With Type 2 And Type 3 Spinal Muscular Atrophy

by | Nov 30, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.